Metlife is a property & casualty insurance company located in New York, United States, which is part of the Financial Services sector, and is traded under the ticker MET on the NYSE exchange.
Metlife stock last closed at $70.40, down 2.96% from the previous day, and has decreased 2.17% in one year. It has underperformed other stocks in the Insurance - Life industry by 0.16 percentage points. Metlife stock is currently +7.96% from its 52-week low of $65.21, and -20.94% from its 52-week high of $89.05.
As of Apr 21, 2025, there are 681.23M shares of MET outstanding. The market value of MET is $47.96B. In the past 24 hours, 3.3M MET shares were traded.
You will need an online brokerage account to access the NYSE market and buy MET shares.
Based on our experience, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal details so you can invest in MET stock today.
Now that you've opened your account on one of the best stock apps, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing funds into your investment account.
Once you have identified the best place to buy Metlife stock, it's very important to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on MET's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge MET's fair value.
Using relative valuations methods:
You can access more valuation research on MET's stock here.
Out of 9 Wall Street analysts who give recommendations on MET, the consensus analyst rating on Metlife is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
John Barnidge, a top 10% analyst from Piper Sandler maintains MET with a strong buy rating and raises their MET price target from $92.00 to $94.00, on Apr 2, 2025.
Piper Sandler's John Barnidge raised their price target on Metlife (NYSE: MET) by 2.2% from $92 to $94 on 2025/04/02. The analyst maintained their Strong Buy rating on the stock.
Barnidge reported that a deep dive into their Financial Services (Insurance) sector coverage catalyzed their price target hike on Metlife.
The analyst said they cut their EPS expectations for the group and shifted their focus to the underwriting sections of "Lifecoland," citing fee and spread challenges.
Problems that fee businesses face, according to Barnidge, include:
Based on their assessment, Barnidge said the spread may face challenges in terms of variable investment income normalization, floater impact, and potential unfavorable commentary over future spread income expectations.
Jimmy Bhullar, a top 16% analyst from JP Morgan maintains MET with a strong buy rating and lowers their MET price target from $88.00 to $86.00, on Apr 2, 2025.
Jack Matten, a bottom 27% analyst from BMO Capital initiates coverage on MET with a hold rating and announces their MET price target of $97.00, on Jan 23, 2025.
Daniel Bergman, a bottom 29% analyst from TD Cowen maintains MET with a strong buy rating and raises their MET price target from $97.00 to $99.00, on Nov 27, 2024.
You can dive deeper into what analysts are forecasting on the Metlife stock forecast page.
Last year, MET earnings were $4.23B. Over the past 5 year, MET's earnings have increased by -0.4% per year. This was slower than the Insurance - Life industry average of 2.43%.
Last year, MET revenue was $70.99B. In the past 5 year, MET's revenue has grown by 0.39% per year. This was faster than the Insurance - Life industry average of -3.26%.
Dive into MET's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at MET have sold more shares than they have bought.
Cheryl W. Grise, Director of MET, was the latest MET insider to buy. They bought $43,826.40 worth of MET stock on Apr 1, 2025.
Learn more about who owns MET shares here.
Metlife pays a dividend of 3.1%, compared to the Insurance - Life industry's average dividend yield of 2.44%. If you owned $1,000 worth of MET stock, you would have received $31.04 in the past 12 months.
Metlife dividend payments have consistently grown over the past decade and have remained stable.
Dig into more data about Metlife dividend yield and history here.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main options:
Click the Open Trade button and your broker will execute the order.
If you need additional assistance investing in stocks on eToro, watch the how to video below:
Now that you own some shares in MET, you'll want to keep up with your stock purchase.
Start a watchlist to get notified of important updates regarding your MET stock.
To summarize, here are the 6 steps for buying Metlife stock:
If you require a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get notifications regarding your new investment in Metlife, create a watchlist on WallStreetZen today.